<?xml version="1.0" encoding="UTF-8"?>
<ref id="B21-pathogens-09-00148">
 <label>21.</label>
 <element-citation publication-type="journal">
  <person-group person-group-type="author">
   <name>
    <surname>Murad</surname>
    <given-names>S.</given-names>
   </name>
   <name>
    <surname>Fuller</surname>
    <given-names>S.</given-names>
   </name>
   <name>
    <surname>Menary</surname>
    <given-names>J.</given-names>
   </name>
   <name>
    <surname>Moore</surname>
    <given-names>C.</given-names>
   </name>
   <name>
    <surname>Pinneh</surname>
    <given-names>E.</given-names>
   </name>
   <name>
    <surname>Szeto</surname>
    <given-names>T.</given-names>
   </name>
   <name>
    <surname>Hitzeroth</surname>
    <given-names>I.</given-names>
   </name>
   <name>
    <surname>Freire</surname>
    <given-names>M.</given-names>
   </name>
   <name>
    <surname>Taychakhoonavudh</surname>
    <given-names>S.</given-names>
   </name>
   <name>
    <surname>Phoolcharoen</surname>
    <given-names>W.</given-names>
   </name>
   <etal/>
  </person-group>
  <article-title>Molecular Pharming for low and middle income countries</article-title>
  <source>Curr. Opin. Biotechnol.</source>
  <year>2019</year>
  <volume>61</volume>
  <fpage>53</fpage>
  <lpage>59</lpage>
  <pub-id pub-id-type="doi">10.1016/j.copbio.2019.10.005</pub-id>
  <pub-id pub-id-type="pmid">31751895</pub-id>
 </element-citation>
</ref>
